Cargando…

Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance

Airway epithelial cells (AECs) display remarkable plasticity in response to infectious stimuli and their functional adaptations are critical for antimicrobial immunity. However, the roles of AECs and humoral mediators to host defense in non-communicable lung inflammation remain elusive. We dissected...

Descripción completa

Detalles Bibliográficos
Autores principales: Boehme, Julia D., Stegemann-Koniszewski, Sabine, Autengruber, Andrea, Peters, Nicole, Wissing, Josef, Jänsch, Lothar, Jeron, Andreas, Bruder, Dunja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504016/
https://www.ncbi.nlm.nih.gov/pubmed/28694492
http://dx.doi.org/10.1038/s41598-017-05212-4
_version_ 1783249199774564352
author Boehme, Julia D.
Stegemann-Koniszewski, Sabine
Autengruber, Andrea
Peters, Nicole
Wissing, Josef
Jänsch, Lothar
Jeron, Andreas
Bruder, Dunja
author_facet Boehme, Julia D.
Stegemann-Koniszewski, Sabine
Autengruber, Andrea
Peters, Nicole
Wissing, Josef
Jänsch, Lothar
Jeron, Andreas
Bruder, Dunja
author_sort Boehme, Julia D.
collection PubMed
description Airway epithelial cells (AECs) display remarkable plasticity in response to infectious stimuli and their functional adaptations are critical for antimicrobial immunity. However, the roles of AECs and humoral mediators to host defense in non-communicable lung inflammation remain elusive. We dissected pulmonary defense against Streptococcus pneumoniae in hosts with pre-existing inflammatory conditions (SPC-HAxTCR-HA mice). Lung tissue transcriptomics and bronchoalveolar lavage fluid (BALF) proteomics revealed an induction of humoral defense mechanisms in inflamed lungs. Accordingly, besides antibacterial proteins and complement components being overrepresented in inflamed lungs, elevated polymeric immunoglobulin receptor (pIgR)-expression in AECs correlated with increased secretory immunoglobulin (SIg) transport. Consequently, opsonization assays revealed augmented pneumococcal coverage by SIgs present in the BALF of SPC-HAxTCR-HA mice, which was associated with enhanced antipneumococcal resistance. These findings emphasize the immunologic potential of AECs as well as their central role in providing antibacterial protection and put forward pIgR as potential target for therapeutic manipulation in infection-prone individuals.
format Online
Article
Text
id pubmed-5504016
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55040162017-07-12 Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance Boehme, Julia D. Stegemann-Koniszewski, Sabine Autengruber, Andrea Peters, Nicole Wissing, Josef Jänsch, Lothar Jeron, Andreas Bruder, Dunja Sci Rep Article Airway epithelial cells (AECs) display remarkable plasticity in response to infectious stimuli and their functional adaptations are critical for antimicrobial immunity. However, the roles of AECs and humoral mediators to host defense in non-communicable lung inflammation remain elusive. We dissected pulmonary defense against Streptococcus pneumoniae in hosts with pre-existing inflammatory conditions (SPC-HAxTCR-HA mice). Lung tissue transcriptomics and bronchoalveolar lavage fluid (BALF) proteomics revealed an induction of humoral defense mechanisms in inflamed lungs. Accordingly, besides antibacterial proteins and complement components being overrepresented in inflamed lungs, elevated polymeric immunoglobulin receptor (pIgR)-expression in AECs correlated with increased secretory immunoglobulin (SIg) transport. Consequently, opsonization assays revealed augmented pneumococcal coverage by SIgs present in the BALF of SPC-HAxTCR-HA mice, which was associated with enhanced antipneumococcal resistance. These findings emphasize the immunologic potential of AECs as well as their central role in providing antibacterial protection and put forward pIgR as potential target for therapeutic manipulation in infection-prone individuals. Nature Publishing Group UK 2017-07-10 /pmc/articles/PMC5504016/ /pubmed/28694492 http://dx.doi.org/10.1038/s41598-017-05212-4 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Boehme, Julia D.
Stegemann-Koniszewski, Sabine
Autengruber, Andrea
Peters, Nicole
Wissing, Josef
Jänsch, Lothar
Jeron, Andreas
Bruder, Dunja
Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
title Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
title_full Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
title_fullStr Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
title_full_unstemmed Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
title_short Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
title_sort chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504016/
https://www.ncbi.nlm.nih.gov/pubmed/28694492
http://dx.doi.org/10.1038/s41598-017-05212-4
work_keys_str_mv AT boehmejuliad chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT stegemannkoniszewskisabine chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT autengruberandrea chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT petersnicole chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT wissingjosef chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT janschlothar chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT jeronandreas chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance
AT bruderdunja chroniclunginflammationprimeshumoralimmunityandaugmentsantipneumococcalresistance